Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Virax Biolabs Group Limited last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 79,919 for the quarter and had revenue of 156,419 for the year. Virax Biolabs Group Limited has generated $-3 earnings per share over the last year ($-3.36 diluted earnings per share) and currently has a price-to-earnings ratio of -0.56. Virax Biolabs Group Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 20th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/20/2024 | Q4 2024 | -$1.71 | $79,919 | $79,919 | ||
09/29/2023 | Q2 2024 | -$1.64 | $76,500 | |||
02/02/2023 | Q4 2023 | -$2.58 | $2,801 | |||
09/29/2022 | Q2 2023 | -$1.24 | $5,760 | |||
08/12/2022 | Q4 2022 | -$1.02 | $-92,865 | |||
09/29/2021 | Q2 2022 | -$0.49 | $0 | |||
03/30/2021 | Q4 2021 | -$0.27 | $109,820 | |||
09/29/2020 | Q2 2021 | -$0.30 | $14,000 | |||
03/30/2020 | Q4 2020 | -$0.02 | $24,969 |
Virax Biolabs Group Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 20th, 2024 based off last year's report dates.
The conference call for Virax Biolabs Group Limited's latest earnings report can be listened to online.
The conference call transcript for Virax Biolabs Group Limited's latest earnings report can be read online.
Virax Biolabs Group Limited (:VRAX) has a recorded annual revenue of $156,419.
Virax Biolabs Group Limited (:VRAX) has a recorded net income of $156,419. Virax Biolabs Group Limited has generated $-3.36 earnings per share over the last four quarters.
Virax Biolabs Group Limited (:VRAX) has a price-to-earnings ratio of -0.56 and price/earnings-to-growth ratio is -0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED